前往化源商城

1,3-双(4-羧基苯氧基)丙烷

1,3-双(4-羧基苯氧基)丙烷结构式
1,3-双(4-羧基苯氧基)丙烷结构式
品牌特惠专场
常用名 1,3-双(4-羧基苯氧基)丙烷 英文名 1 3-BIS(P-CARBOXYPHENOXY)PROPANE
CAS号 3753-81-9 分子量 316.30500
密度 1.318g/cm3 沸点 533.5ºC at 760 mmHg
分子式 C17H16O6 熔点 310ºC(lit.)
MSDS 中文版 美版 闪点 196.7ºC
符号 GHS07 GHS09
GHS07, GHS09
信号词 Warning

One type of novel thermosensitive polymeric micelles

J. Control. Release 152 Suppl 1 , e127-8, (2011)

Design of an injectable system based on bioerodible polyanhydride microspheres for sustained drug delivery.

Biomaterials 23 , 4405, (2002)

The fabrication, morphological characterization, and drug release kinetics from microspheres of three bioerodible polyanhydrides, poly[1,6-bis(p-carboxyphenoxy)hexane] (poly(CPH)), poly(sebacic anhydride) (poly(SA)), and the copolymer poly(CPH-co-SA) 50:50 (C...

Urich, K.E. et al.

Macromolecules 28 , 2184, (1995)

Metabolic disposition and elimination studies of a radiolabelled biodegradable polymeric implant in the rat brain.

Biomaterials 15(9) , 681-8, (1994)

The metabolic disposition and elimination process of the anhydride co-polymer poly[1,3-bis(p-carboxy-phenoxypropane):sebacic acid] 20:80 [P(CPP:Sa)20:80] implanted in the rat brain was studied. Two polymers were prepared, one with [14C]SA and unlabelled CPP, ...

Excretion of a radiolabelled anticancer biodegradable polymeric implant from the rabbit brain.

Biomaterials 16(14) , 1069-72, (1995)

The elimination of a clinically used anticancer biodegradable polymer implant (Gliadel) in the rabbit brain was studied. The implant is composed of N,N-bis(2-chloroethyl)-N-nitrosourea (BCNU) (1.6 wt%) dispersed in a copolyanhydride matrix of 1,3-bis(p-carbox...

Molecular weight changes in polymer erosion.

Pharm. Res. 9(10) , 1279-83, (1992)

We report a study of the effects of polymer molecular weight on the erosion of polyanhydride copolymer matrices composed of 1,3-bis(p-carboxyphenoxy)-propane (CPP) and sebacic acid (SA) in aqueous solution. The erosion profile characteristically displays an i...

Pulsatile release of parathyroid hormone from an implantable delivery system.

Biomaterials 28(28) , 4124-31, (2007)

Intermittent (pulsatile) administration of parathyroid hormone (PTH) is known to improve bone micro-architecture, mineral density and strength. Therefore, daily injection of PTH has been clinically used for the treatment of osteoporosis. However, this regimen...

Comparison of metabolic effects of ziprasidone versus olanzapine treatment in patients with first-episode schizophrenia.

Macromol. Biosci. 7(5) , 620-8, (2007)

The objective of the study was to compare metabolic effects of ziprasidone versus olanzapine treatment in patients with first-episode schizophrenia.In this 6-week, multicenter, open-label trial, 260 patients were randomly assigned to receive ziprasidone or ol...

Synthesis and characterization of polyanhydride for local BCNU delivery carriers.

Biomed Mater Eng 15(3) , 229-38, (2005)

p-Carboxyphenoxy propane (CPP) prepolymer consisting of 4 units and sebacic acid (SA) prepolymer consisting of about 10 units were synthesized by reacting CPP and SA in the presence of excess acetic anhydride, respectively. Polyanhydride, poly(CPP-SA) copolym...